https://thepharmadata.com/roche-enters-into-a-definitive-merger-agreement-to-acquire-carmot-therapeutics-including-three-clinical-stage-assets-with-best-in-class-potential-in-obesity-and-diabetes/ 2023-12-06T05:45:11+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/diabetes.webp https://thepharmadata.com/fda-grants-priority-review-to-mercks-application-for-keytruda-pembrolizumab-plus-padcev-enfortumab-vedotin-ejfv-for-the-first-line-treatment-of-patients-with-locally-advanced/ 2023-12-06T05:42:52+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/breast-cancer.webp https://thepharmadata.com/takeda-to-present-data-at-65th-american-society-of-hematology-ash-annual-meeting-demonstrating-continued-commitment-to-patients-with-hematologic-diseases/ 2023-11-28T11:53:05+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Meeting-_4_.webp https://thepharmadata.com/bayer-and-hurdle-launch-precision-health-strategic-partnership/ 2023-11-28T11:50:21+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/partnerships.webp https://thepharmadata.com/dupixent-significantly-reduced-copd-exacerbations-in-second-positive-phase-3-trial-accelerating-fda-submission-and-confirming-potential-to-become-first-approved-biologic-for-this-serious-diseas/ 2023-11-28T11:44:26+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Approves.webp https://thepharmadata.com/novartis-upgrades-mid-term-sales-growth-guidance-showcases-its-differentiated-innovative-medicines-strategy-and-robust-pipeline-at-rd-day/ 2023-11-28T11:42:35+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Medicines-_2_.webp https://thepharmadata.com/roche-expands-hepatitis-diagnostics-portfolio-to-help-clinicians-diagnose-and-monitor-patients-with-acute-or-chronic-hepatitis-b-infection/ 2023-11-28T11:39:30+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/Diagnosed.webp https://thepharmadata.com/cn-bio-wins-most-impactful-industry-collaboration-of-the-year-at-the-obn-awards-2023-for-ongoing-research-with-the-fda/ 2023-11-25T05:01:42+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-cottonbro-studio-6565255.webp https://thepharmadata.com/boehringer-ingelheim-receives-approval-for-senvelgo-in-europe-the-first-oral-liquid-medication-for-diabetic-cats/ 2023-11-25T04:56:38+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-nataliya-vaitkevich-5863403.webp https://thepharmadata.com/transmucosal-drug-delivery-pipeline-report-2023-stages-of-development-segments-region-and-countries-regulatory-path-and-key-companies-researchandmarkets-com/ 2023-11-25T04:53:44+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/drug.webp https://thepharmadata.com/chugai-launches-phesgo-subcutaneous-combination-for-the-treatment-of-her2-positive-breast-and-colorectal-cancer/ 2023-11-25T04:49:23+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/cancer.jpg https://thepharmadata.com/novo-nordisk-invests-more-than-16-billion-danish-kroner-in-expansion-of-production-facilities-in-chartres-france/ 2023-11-25T04:44:44+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-morthy-jameson-9588206.webp https://thepharmadata.com/bayer-invests-130-million-eur-in-new-production-facility-for-innovative-parenteral-products/ 2023-11-25T04:44:01+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-david-mcbee-730547.webp https://thepharmadata.com/bayer-championing-advancements-in-radiology-pipeline-and-accelerating-ai-innovation/ 2023-11-25T04:40:21+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-mart-production-7089017-1.webp https://thepharmadata.com/vertex-announces-european-medicines-agency-validation-for-marketing-authorization-application-extension-for-kaftrio-in-combination-with-ivacaftor-to-include-people-with-cystic-fibrosis-and/ 2023-11-25T04:24:26+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces.webp https://thepharmadata.com/european-commission-approves-kaftrio-in-combination-with-ivacaftor-for-the-treatment-of-children-with-cystic-fibrosis-ages-2-through-5/ 2023-11-25T04:22:58+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-guduru-ajay-bhargav-939702.webp https://thepharmadata.com/amgen-to-present-at-the-evercore-isi-healthconx-conference/ 2023-11-25T04:18:35+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Conference.webp https://thepharmadata.com/marinus-pharmaceuticals-announces-seven-presentations-at-aes-2023-new-publication-in-epilepsia-and-results-from-the-second-generation-formulation-mad-study/ 2023-11-21T04:59:58+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-%E7%A5%9D-%E9%B9%A4%E6%A7%90-716281.webp https://thepharmadata.com/cel-sci-announces-closing-of-5-million-public-offering-of-common-stock/ 2023-11-21T04:54:44+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-brett-sayles-5326740.webp https://thepharmadata.com/imfinzi-plus-chemotherapy-approved-in-china-as-first-immunotherapy-regimen-for-patients-with-locally-advanced-or-metastatic-biliary-tract-cancer/ 2023-11-21T04:51:53+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/cancer.jpg https://thepharmadata.com/fda-approves-mercks-keytruda-pembrolizumab-plus-chemotherapy-as-first-line-treatment-for-locally-advanced-unresectable-or-metastatic-her2-negative-gastric-or-gastroesophageal-junction/ 2023-11-21T04:50:51+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Approves.webp https://thepharmadata.com/morphosys-phase-3-study-of-pelabresib-in-myelofibrosis-demonstrates-statistically-significant-improvement-in-spleen-volume-reduction-and-strong-positive-trend-in-symptom-reduction/ 2023-11-21T04:50:42+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-mikael-blomkvist-6476589.webp https://thepharmadata.com/astrazeneca-launches-evinova-a-health-tech-business-to-accelerate-innovation-across-the-life-sciences-sector-the-delivery-of-clinical-trials-and-better-health-outcomes/ 2023-11-21T04:50:27+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-chokniti-khongchum-3938023.webp https://thepharmadata.com/prospection-ai-launches-as-the-single-source-patient-centric-intelligence-platform-to-strengthen-drug-commercialization/ 2023-11-21T04:49:55+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/drug.webp https://thepharmadata.com/colibri-group-announces-strategic-acquisition-of-trc-healthcare/ 2023-11-21T04:46:21+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces.webp https://thepharmadata.com/iaso-bio-establishes-international-car-t-diagnostic-and-treatment-center-in-china-to-serve-mm-patients-worldwide/ 2023-11-21T04:41:36+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/treatment.webp https://thepharmadata.com/oceanic-af-study-stopped-early-due-to-lack-of-efficacy/ 2023-11-21T04:27:22+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-pixabay-261909.webp https://thepharmadata.com/diagnostic-collaboration-and-licensing-deals-analysis-report-and-directory-2023-comprehensive-insights-on-agreements-made-by-major-biopharmaceutical-companies-globally-researchandmarkets-com/ 2023-11-17T11:19:52+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-sevenstorm-juhaszimrus-443383.webp https://thepharmadata.com/puretech-founded-entity-karuna-therapeutics-announces-positive-results-from-phase-1b-ambulatory-blood-pressure-monitoring-trial-of-karxt-in-schizophrenia/ 2023-11-17T11:17:13+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-thirdman-7659573.webp https://thepharmadata.com/roche-launches-automated-serology-hepatitis-e-virus-tests-including-a-test-to-detect-acute-hev-infections-recommended-in-the-new-who-2023-essential-diagnostics-list/ 2023-11-17T10:53:31+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-mart-production-7089619.webp https://thepharmadata.com/truqap-capivasertib-plus-faslodex-approved-in-the-us-for-patients-with-advanced-hr-positive-breast-cancer/ 2023-11-17T10:49:41+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/breast-cancer-1.webp https://thepharmadata.com/kite-and-arcellx-announce-expansion-in-strategic-partnership/ 2023-11-17T10:46:22+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/partnerships.jpg https://thepharmadata.com/vertex-and-crispr-therapeutics-announce-authorization-of-the-first-crispr-cas9-gene-edited-therapy-casgevy-exagamglogene-autotemcel-by-the-united-kingdom-mhra-for-the-treatment-of-si/ 2023-11-17T10:44:01+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces.webp https://thepharmadata.com/chugai-receives-the-best-ir-award-the-greatest-ir-improvement-premium-companies-and-the-best-continual-ir-efforts-premium-companies/ 2023-11-17T10:40:30+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-nataliya-vaitkevich-6532373.webp https://thepharmadata.com/roches-subcutaneous-injection-of-tecentriq-recommended-by-the-eus-chmp-for-multiple-cancer-types/ 2023-11-14T11:46:48+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-rfstudio-3825529.webp https://thepharmadata.com/update-on-pacific-2-phase-iii-trial-of-imfinzi-concurrently-administered-with-platinum-based-chemoradiotherapy-in-unresectable-stage-iii-non-small-cell-lung-cancer/ 2023-11-14T11:43:25+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/lung-cancer.webp https://thepharmadata.com/regeneron-commits-34-million-over-five-years-to-continue-to-sponsor-the-regeneron-international-science-and-engineering-fair-isef/ 2023-11-14T11:35:28+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Science-Research.webp https://thepharmadata.com/gsk-receives-positive-chmp-opinion-recommending-momelotinib-for-myelofibrosis-patients-with-anaemia/ 2023-11-14T11:32:29+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-pavel-danilyuk-7653310.webp https://thepharmadata.com/bayer-foundation-presents-science-awards/ 2023-11-14T11:26:15+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-nataliya-vaitkevich-6532373.webp https://thepharmadata.com/bayer-collaboration-with-microsoft-connects-farm-data-to-address-lack-of-data-interoperability-in-agriculture/ 2023-11-14T11:21:25+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-math-21393.webp https://thepharmadata.com/askbio-presents-preliminary-data-from-phase-1-trial-of-gene-therapy-for-congestive-heart-failure-chf-at-the-2023-american-heart-association-scientific-sessions/ 2023-11-14T11:15:33+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/pexels-karolina-grabowska-4386466.webp https://thepharmadata.com/novo-nordisk-invests-more-than-42-billion-danish-kroner-in-expansion-of-manufacturing-facilities-in-kalundborg-denmark/ 2023-11-10T10:31:42+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Investment-scaled.webp https://thepharmadata.com/roches-elecsys-nfl-test-an-important-aid-for-those-living-with-multiple-sclerosis-is-granted-fda-breakthrough-device-designation/ 2023-11-10T10:30:29+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Conference-Call.webp https://thepharmadata.com/astrazeneca-licenses-novel-agent-for-the-treatment-of-cardiometabolic-conditions-and-obesity/ 2023-11-10T10:27:51+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Treatment-_4_.webp https://thepharmadata.com/imfinzi-plus-bevacizumab-met-primary-endpoint-for-progression-free-survival-in-liver-cancer-eligible-for-embolisation-in-emerald-1-phase-iii-trial/ 2023-11-10T10:26:26+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/liver-cancer-_2_.webp https://thepharmadata.com/bayer-and-recursion-focus-research-collaboration-on-oncology/ 2023-11-10T10:22:45+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/Oncology-_4_-scaled.webp https://thepharmadata.com/takedas-adzynma-approved-by-u-s-fda-as-the-first-and-only-recombinant-adamts13-enzyme-replacement-therapy-for-the-treatment-of-congenital-thrombotic-thrombocytopenic-purpura/ 2023-11-10T10:18:38+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Approves.webp https://thepharmadata.com/advancell-announces-first-patient-dosed-in-phase-i-ii-therapb-clinical-trial-of-212pb-advc001-in-metastatic-prostate-cancer/ 2023-11-08T07:14:35+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces-2.webp https://thepharmadata.com/new-research-shows-high-accuracy-of-precivity-blood-biomarkers-in-the-evaluation-of-brain-amyloid-in-pre-clinical-alzheimers-disease/ 2023-11-08T07:13:09+00:00 https://thepharmadata.com/wp-content/uploads/2023/10/Health-Research.webp https://thepharmadata.com/biophy-launches-breakthrough-ai-platform-to-accelerate-the-trillion-dollar-drug-development-market/ 2023-11-08T07:11:47+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/Drug-Development-_2_.webp https://thepharmadata.com/marinus-pharmaceuticals-inicia-programa-de-acesso-mundial-para-cv-de-suspensao-oral-do-ztalmy/ 2023-11-08T07:07:35+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/Appoints-_3_.webp https://thepharmadata.com/amgen-presents-new-research-in-early-psoriatic-arthritis-at-acr-2023/ 2023-11-08T07:03:51+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/RESEARCH-_2_.webp https://thepharmadata.com/gilead-and-kite-oncology-present-data-demonstrating-car-t-cell-therapy-survival-benefit-and-showcasing-latest-advances-in-blood-cancer-portfolio-at-ash-2023/ 2023-11-08T06:28:18+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/Blood-Cancer.webp https://thepharmadata.com/gilead-and-arcus-announce-new-data-showing-encouraging-clinical-activity-of-anti-tigit-domvanalimab-containing-regimen-as-first-line-treatment-for-upper-gi-cancers/ 2023-11-08T06:25:09+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/announces-_4_.webp https://thepharmadata.com/vertex-to-present-data-highlighting-long-term-benefits-of-trikafta-at-the-north-american-cystic-fibrosis-conference/ 2023-11-08T06:22:53+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/Conference-2.jpg https://thepharmadata.com/moderna-tops-biospaces-best-places-to-work-ranking-for-third-consecutive-year/ 2023-11-08T06:15:44+00:00 https://thepharmadata.com/wp-content/uploads/2023/11/Work-Ranking.jpg https://thepharmadata.com/biogen-appoints-monish-patolawala-to-its-board-of-directors/ 2023-11-08T06:12:32+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Appoints.webp https://thepharmadata.com/seagen-highlights-first-solid-tumor-data-for-an-adcetris-immunotherapy-combination-and-preclinical-data-for-novel-cd30-directed-antibody-drug-conjugate-at-society-for-immunotherapy-of-cancer-sitc-an/ 2023-11-08T06:10:58+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Meeting-2.webp https://thepharmadata.com/roche-announces-embark-trial-in-duchenne-muscular-dystrophy-did-not-reach-primary-endpoint-but-shows-positive-efficacy-outcomes-on-all-timed-functional-key-endpoints/ 2023-10-31T05:59:19+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces-2-1.webp https://thepharmadata.com/novartis-investigational-atrasentan-phase-iii-study-demonstrates-clinically-meaningful-and-highly-statistically-significant-proteinuria-reduction-in-patients-with-iga-nephropathy/ 2023-10-31T05:54:18+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/Adult-Patients.webp https://thepharmadata.com/merck-strengthens-oncology-pipeline-through-strategic-partnership-with-hengrui-for-next-generation-selective-parp1-inhibitor-and-antibody-drug-conjugate/ 2023-10-31T05:49:12+00:00 https://thepharmadata.com/wp-content/uploads/2023/10/Partnership-_2_.webp https://thepharmadata.com/phase-iii-ruby-trial-of-jemperli-plus-chemotherapy-meets-endpoint-of-overall-survival-in-patients-with-primary-advanced-or-recurrent-endometrial-cancer/ 2023-10-31T05:39:27+00:00 https://thepharmadata.com/wp-content/uploads/2023/10/chemotherapy-_5_.webp https://thepharmadata.com/cepi-and-moderna-harness-mrna-technology-to-advance-100-days-mission/ 2023-10-31T05:36:26+00:00 https://thepharmadata.com/wp-content/uploads/2023/10/meetings.webp https://thepharmadata.com/boehringer-ingelheims-spevigo-wins-2023-prix-galien-usa-best-orphan-rare-diseases-solution-award/ 2023-10-28T05:21:17+00:00 https://thepharmadata.com/wp-content/uploads/2023/10/Diseases.webp https://thepharmadata.com/immunis-chairman-dr-hans-keirstead-to-present-at-bio-europe-conference-in-germany/ 2023-10-28T05:15:34+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Conference.webp https://thepharmadata.com/fda-approves-roches-vabysmo-for-the-treatment-of-retinal-vein-occlusion/ 2023-10-28T05:13:46+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/APPROVAL-_2_.webp https://thepharmadata.com/gsk-launches-6m-programme-to-boost-stem-career-progression-for-young-people-from-under-represented-groups-in-the-uk/ 2023-10-28T05:08:38+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Meeting-_4_.webp https://thepharmadata.com/moderna-named-a-top-employer-by-science-for-ninth-consecutive-year/ 2023-10-28T05:06:10+00:00 https://thepharmadata.com/wp-content/uploads/2023/10/Employe.webp https://thepharmadata.com/johnson-johnson-announces-departure-of-ashley-mcevoy-tim-schmid-named-executive-vice-president-worldwide-chairman-of-medtech/ 2023-10-24T07:47:04+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces-2-1.webp https://thepharmadata.com/imfinzi-plus-lynparza-reduced-the-risk-of-disease-progression-or-death-by-45-vs-chemotherapy-in-advanced-or-recurrent-endometrial-cancer/ 2023-10-24T07:43:15+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/cancer.jpg https://thepharmadata.com/soliris-approved-in-china-for-the-treatment-of-adults-with-neuromyelitis-optica-spectrum-disorder-nmosd/ 2023-10-24T07:42:08+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Leadership.webp https://thepharmadata.com/fda-approves-penbraya-the-first-and-only-vaccine-for-the-prevention-of-the-five-most-common-serogroups-causing-meningococcal-disease-in-adolescents/ 2023-10-24T07:38:28+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/Approval.webp https://thepharmadata.com/amgen-presents-new-tarlatamab-data-in-small-cell-lung-cancer/ 2023-10-24T07:36:52+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/lung-cancer.webp https://thepharmadata.com/amgen-to-webcast-investor-call-at-esmo-2023/ 2023-10-24T07:35:48+00:00 https://thepharmadata.com/wp-content/uploads/2023/10/INVESTOR-CALL.webp https://thepharmadata.com/sanofi-delivers-first-medicines-from-global-health-units-impact-brand-portfolio/ 2023-10-24T07:33:06+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/2023-global.webp https://thepharmadata.com/gilead-sciences-announces-new-clinical-trial-in-europe-to-assess-lenacapavir-for-hiv-prevention-as-part-of-landmark-purpose-program/ 2023-10-24T07:30:38+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/Clinical.webp https://thepharmadata.com/gilead-and-assembly-biosciences-establish-partnership-to-develop-next-generation-therapeutics-for-serious-viral-diseases/ 2023-10-24T07:29:32+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/partnerships.webp https://thepharmadata.com/regeneron-builds-on-together-for-change-initiative-with-five-year-5-million-commitment-to-fuel-the-stem-talent-pipeline-in-nashville-tn/ 2023-10-24T07:26:00+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/million.webp https://thepharmadata.com/together-for-change-genomics-and-equity-initiative-launched-by-a-coalition-of-meharry-medical-college-regeneron-genetics-center-astrazeneca-novo-nordisk-and-roche-to-improve-health-outcomes-for-pe/ 2023-10-24T07:24:56+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Meeting-_4_.webp https://thepharmadata.com/european-commission-approves-adcetris-for-the-treatment-of-adult-patients-with-previously-untreated-cd30-stage-iii-hodgkin-lymphoma-in-combination-with-avd/ 2023-10-24T07:17:59+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/lymphoma.webp https://thepharmadata.com/takeda-settles-tax-dispute-with-irish-revenue-over-break-fee-received-by-shire/ 2023-10-24T07:16:50+00:00 https://thepharmadata.com/wp-content/uploads/2023/10/Offers.jpg https://thepharmadata.com/takeda-announces-topline-results-of-phase-3-admire-cd-ii-trial-of-alofisel-in-complex-crohns-perianal-fistulas/ 2023-10-24T07:14:44+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/announces-_4_.webp https://thepharmadata.com/dating-foreign-women-can-be-a-rewarding-and-enhancing-experience/ 2023-10-18T06:15:00+00:00 https://thepharmadata.com/depuy-synthes-receives-fda-clearance-for-trileap-lower-extremity-anatomic-plating-system/ 2023-10-14T08:00:51+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Approves.webp https://thepharmadata.com/rd-postdoctoral-challenge-is-a-ground-breaking-initiative-fostering-collaboration-innovation-and-global-diversity/ 2023-10-14T07:57:25+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/announces-_4_.webp https://thepharmadata.com/s-fda-approves-pfizers-velsipity-for-adults-with-moderately-to-severely-active-ulcerative-colitis/ 2023-10-14T07:54:58+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/Approval.webp https://thepharmadata.com/u-s-fda-approves-pfizers-braftovi-mektovi-for-braf-v600e-mutant-metastatic-non-small-cell-lung-cancer/ 2023-10-14T07:54:00+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/approves-_2_.webp https://thepharmadata.com/bayer-invests-250-million-usd-in-new-cell-therapy-manufacturing-facility-in-the-u-s/ 2023-10-14T07:04:31+00:00 https://thepharmadata.com/wp-content/uploads/2023/10/invest.webp https://thepharmadata.com/merck-highlights-innovative-oncology-portfolio-and-pipeline-at-esmo-congress-2023-underscoring-commitment-to-advancing-cancer-research-and-improving-patient-outcomes-across-multiple-stages-of-disease/ 2023-10-10T11:44:00+00:00 https://thepharmadata.com/wp-content/uploads/2023/10/Health-Research.webp https://thepharmadata.com/merck-announces-pivotal-keynote-671-trial-meets-dual-primary-endpoint-of-overall-survival-in-resectable-stage-ii-iiia-or-iiib-non-small-cell-lung-cancer/ 2023-10-10T11:42:47+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/cancer.jpg https://thepharmadata.com/roches-vabysmo-maintained-vision-improvements-with-extended-treatment-intervals-up-to-four-months-for-people-with-retinal-vein-occlusion-rvo-in-phase-iii-studies/ 2023-10-10T11:41:00+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Treatment-_4_.webp https://thepharmadata.com/janssen-highlights-latest-research-for-tremfya-and-investigational-targeted-oral-peptide-jnj-2113-in-moderate-to-severe-plaque-psoriasis-at-the-european-academy-of-dermatology-and-venereology-congress/ 2023-10-10T11:38:59+00:00 https://thepharmadata.com/wp-content/uploads/2023/10/Congress.webp https://thepharmadata.com/anebulo-pharmaceuticals-announces-new-ceo/ 2023-10-07T05:41:34+00:00 https://thepharmadata.com/wp-content/uploads/2023/10/CEO.webp https://thepharmadata.com/revbio-awarded-a-3-4-million-nih-grant-for-its-novel-regenerative-bone-adhesive-to-treat-complex-fractures/ 2023-10-07T05:37:57+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Leadership.webp https://thepharmadata.com/ais-healthcares-advanced-infusion-care-team-presents-at-immunoglobulin-national-society-conference/ 2023-10-07T05:36:00+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/Approval.webp https://thepharmadata.com/navidea-biopharmaceuticals-inc-announces-nyse-americans-decision-to-suspend-trading-in-its-common-stock/ 2023-10-07T05:31:30+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/announces-_4_.webp https://thepharmadata.com/amylyx-pharmaceuticals-provides-update-on-acces-compassionnel-for-amx0035-in-france/ 2023-10-07T05:29:07+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Update-2.webp https://thepharmadata.com/pfizer-presents-new-data-at-idweek-2023-highlighting-advances-in-prevention-and-treatment-of-certain-respiratory-illnesses-and-other-infectious-diseases/ 2023-10-07T05:16:56+00:00 https://thepharmadata.com/wp-content/uploads/2023/10/Infectious-Diseases.webp https://thepharmadata.com/thermo-fisher-scientific-expands-st-louis-manufacturing-for-complex-biologic-treatments/ 2023-10-07T05:14:11+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Treatment-_4_.webp https://thepharmadata.com/stevanato-group-announces-voting-results-from-its-extraordinary-general-meeting/ 2023-10-07T05:12:47+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Meeting.webp https://thepharmadata.com/elligo-health-research-announces-expansion-of-study-marketplace-with-syneos-health/ 2023-10-07T05:10:10+00:00 https://thepharmadata.com/wp-content/uploads/2023/10/Health-Research.webp https://thepharmadata.com/lokavant-announces-8m-strategic-investment-from-mitsui-co-to-expand-ai-and-predictive-clinical-trial-intelligence-into-asia-pacific/ 2023-10-03T12:13:35+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces-2-1.webp https://thepharmadata.com/bridgebio-and-resilience-announce-strategic-multi-year-partnership-to-advance-bbp-631-bbp-812-and-future-gene-therapy-treatments/ 2023-10-03T12:12:09+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announcement.webp https://thepharmadata.com/mindmed-to-present-data-on-the-preclinical-activity-of-mm-402-at-the-36th-annual-european-college-of-neuropsychopharmacology-ecnp-congress/ 2023-10-03T12:11:00+00:00 https://thepharmadata.com/wp-content/uploads/2023/10/Medicine-2.webp https://thepharmadata.com/promega-to-develop-microsatellite-instability-msi-companion-diagnostic-ivd-kit-in-collaboration-with-gsk/ 2023-10-03T12:07:11+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/partnerships.jpg https://thepharmadata.com/hey-jane-launches-comprehensive-reproductive-and-sexual-health-services-in-the-district-of-columbia/ 2023-10-03T12:05:51+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/healthier.webp https://thepharmadata.com/rockwell-medical-enters-into-3-year-product-purchase-agreement-with-centers-for-dialysis-care/ 2023-10-03T12:04:18+00:00 https://thepharmadata.com/wp-content/uploads/2023/08/pexels-louis-bauer-249348.webp https://thepharmadata.com/sphere-fluidics-cyto-mine-system-selected-by-fairjourney-biologics-to-advance-cell-line-development-workflows/ 2023-10-03T12:02:19+00:00 https://thepharmadata.com/wp-content/uploads/2023/10/Workflows.jpg https://thepharmadata.com/automata-technologies-40m-fundraise-backed-by-dimension-and-a-p-moller-holding-to-expand-growing-life-science-lab-automation-offering/ 2023-10-03T11:59:11+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/partnership.webp https://thepharmadata.com/gilead-board-director-kevin-e-lofton-named-to-list-of-influential-leaders/ 2023-10-03T11:56:01+00:00 https://thepharmadata.com/wp-content/uploads/2023/10/Leaders.webp https://thepharmadata.com/advent-international-and-warburg-pincus-complete-acquisition-of-baxters-biopharma-solutions-business/ 2023-10-03T11:53:56+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Meeting-2.webp https://thepharmadata.com/understanding-an-asian-woman-s-traditions-and-desire-to-marry/ 2023-10-01T03:47:39+00:00 https://thepharmadata.com/bausch-lomb-completes-acquisition-of-xiidra/ 2023-09-30T06:08:34+00:00 https://thepharmadata.com/wp-content/uploads/2023/08/Announces-3.webp https://thepharmadata.com/ew-analysis-highlights-importance-of-adhering-to-uninterrupted-full-course-of-treatment-with-tepezzato-support-thyroid-eye-disease-patient-outcomes/ 2023-09-30T06:06:54+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/Thyroid-Eye-Disease.webp https://thepharmadata.com/gedi-cube-and-renovaro-biosciences-sign-definitive-agreement-to-combine/ 2023-09-30T06:01:10+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/agreements.webp https://thepharmadata.com/faeth-therapeutics-appoints-debbie-chirnomas-m-d-m-p-h-as-chief-medical-officer/ 2023-09-30T05:58:47+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/Medical-Officer.webp https://thepharmadata.com/cimeio-therapeutics-announces-publication-of-seminal-epitope-editing-work-in-the-journal-of-experimental-medicine/ 2023-09-30T05:55:41+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/announces-_4_.webp https://thepharmadata.com/united-therapeutics-announces-recent-milestones-for-its-heart-and-kidney-xenotransplantation-programs/ 2023-09-24T08:32:01+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces-2-1.webp https://thepharmadata.com/ligands-partner-jazz-pharmaceuticals-receives-european-commission-approval-for-enrylaze-a-recombinant-erwinia-asparaginase-or-crisantaspase-for-the-treatment-of-acute-lymphoblast/ 2023-09-24T08:28:04+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/Approval.webp https://thepharmadata.com/thought-leaders-at-the-zayed-prize-for-sustainable-development-forum-chart-paths-forward-to-promote-progress-for-people-and-planet/ 2023-09-24T08:27:00+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/leaders.webp https://thepharmadata.com/datopotamab-deruxtecan-demonstrated-a-statistically-significant-and-clinically-meaningful-progression-free-survival-benefits-in-patients-with-hr-positive-her2-low-or-negative-breast-cancer-in-t/ 2023-09-24T08:17:17+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/breast-cancer-1.webp https://thepharmadata.com/bristol-myers-squibb-announces-perioperative-regimen-of-neoadjuvant-opdivo-nivolumab-and-chemotherapy-followed-by-adjuvant-opdivo-significantly-improves-event-free-survival-in-pa/ 2023-09-24T08:12:57+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/announces-_4_.webp https://thepharmadata.com/merck-and-eisai-provide-update-on-two-phase-3-trials-evaluating-keytruda-plus-lenvima-in-patients-with-certain-types-of-metastatic-non-small-cell-lung-cancer/ 2023-09-24T08:10:39+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/breast-cancer.webp https://thepharmadata.com/vividion-therapeutics-starts-phase-i-clinical-trial-in-advanced-solid-tumors-with-keap1-activator/ 2023-09-20T05:01:28+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Clinical-_3_.webp https://thepharmadata.com/a-suit-of-armor-for-cancer-fighting-cells/ 2023-09-20T05:00:06+00:00 https://thepharmadata.com/wp-content/uploads/2023/08/pexels-edward-jenner-4033151.webp https://thepharmadata.com/biocytogen-officially-launches-the-renmice/ 2023-09-16T05:45:02+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Appoints-_3_.webp https://thepharmadata.com/emulate-publishes-novel-framework-to-pave-the-way-for-the-integration-of-liver-chip-technology-into-pharmaceutical-safety-assessment/ 2023-09-16T05:23:01+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/Pharmaceutical-Safety.webp https://thepharmadata.com/quizartinib-recommended-for-approval-in-eu-by-chmp-for-patients-with-newly-diagnosed-flt3-itd-positive-aml/ 2023-09-16T05:19:39+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/Diagnosed.webp https://thepharmadata.com/merck-receives-positive-eu-chmp-opinion-for-keytruda-as-adjuvant-treatment-for-adults-with-non-small-cell-lung-cancer-at-high-risk-of-recurrence-following-complete-resection-and-platinum-based-chemoth/ 2023-09-16T05:17:25+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/lung-cancer.webp https://thepharmadata.com/ebglyss-receives-positive-chmp-opinion-for-moderate-to-severe-atopic-dermatitis/ 2023-09-16T05:12:38+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Approvals.webp https://thepharmadata.com/global-cell-freezing-media-market-to-reach-291-3-million-by-2030-driven-by-rising-adoption-of-ready-to-use-freezing-media-researchandmarkets-com/ 2023-09-16T05:09:29+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/Media-Market.webp https://thepharmadata.com/agc-biologics-offers-guaranteed-delivery-of-at-least-1e11-tu-of-lvv-material-in-nine-months/ 2023-09-14T11:24:40+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/Offers.webp https://thepharmadata.com/biomedicines-announces-close-of-273m-series-c-financing-to-advance-its-generative-ai-pipeline-of-preclinical-and-clinical-protein-therapeutics/ 2023-09-14T11:20:59+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces-2-1.webp https://thepharmadata.com/boehringer-ingelheim-receives-sbti-validation-for-co2-reduction-targets/ 2023-09-14T11:19:40+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Research.webp https://thepharmadata.com/astrazeneca-advances-uk-clean-heat-and-energy-efficiencies-with-100m-commitment/ 2023-09-14T11:18:13+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/UK.webp https://thepharmadata.com/rs-oncology-announces-new-preclinical-data-showing-that-rso-021-can-block-and-or-reverse-the-progression-of-aggressive-mesotheliomas-improving-drug-availability/ 2023-09-14T11:14:53+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/announces-_4_.webp https://thepharmadata.com/takeda-commits-more-than-30-million-to-five-new-global-csr-partnerships-to-boost-health-impact-in-92-countries/ 2023-09-14T11:11:37+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/partnerships.jpg https://thepharmadata.com/ahead-of-un-general-assembly-pharmaceutical-industry-calls-attention-to-need-for-pandemic-preparedness-plans-to-support-innovation-and-equity/ 2023-09-14T11:08:38+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Pharmaceuticals.webp https://thepharmadata.com/study-result-of-orelabrutinib-in-patients-with-r-r-mzl-published-by-american-journal-of-hematology/ 2023-09-14T10:24:08+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/Adult-Patients.webp https://thepharmadata.com/irlca-and-ead-unveil-dynamic-partnership-to-shape-the-future-of-compliance-and-technology-for-the-life-sciences-industry/ 2023-09-13T11:35:09+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/partnership.webp https://thepharmadata.com/turmeric-may-be-as-good-for-treating-indigestion-as-drug-to-curb-excess-stomach-acid/ 2023-09-13T07:53:56+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/drug.webp https://thepharmadata.com/novartis-presents-new-long-term-leqvio-inclisiran-data-demonstrating-consistent-efficacy-and-safety-beyond-six-years/ 2023-09-09T06:53:44+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces-2-1.webp https://thepharmadata.com/sandoz-receives-fda-approval-for-tyruko-natalizumab-sztn-first-and-only-fda-approved-biosimilar-for-relapsing-forms-of-multiple-sclerosis/ 2023-09-09T06:53:13+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Approvals.webp https://thepharmadata.com/merck-and-eisai-provide-update-on-phase-3-leap-010-trial-evaluating-keytruda-pembrolizumab-plus-lenvima-lenvatinib-in-patients-with-certain-types-of-recurrent-or-metastatic-head-and-ne/ 2023-09-09T06:52:10+00:00 https://thepharmadata.com/wp-content/uploads/2023/08/pexels-rdne-stock-project-6129158.webp https://thepharmadata.com/lillys-retevmo-selpercatinib-demonstrates-superior-progression-free-survival-compared-to-approved-multikinase-inhibitors-in-ret-mutant-medullary-thyroid-cancer/ 2023-09-09T06:51:00+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/cancer.jpg https://thepharmadata.com/dr-patrick-fox-named-president-of-amerigroup-new-jersey/ 2023-09-09T05:44:24+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Development.webp https://thepharmadata.com/a-free-online-tool-can-help-prostate-cancer-patients-save-on-out-of-pocket-drug-costs/ 2023-09-08T12:04:43+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/drug-development.webp https://thepharmadata.com/european-commission-expands-mercks-erveboindication-to-include-children-1-year-of-age-and-older/ 2023-09-08T11:59:42+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Meeting-2.webp https://thepharmadata.com/roche-and-alnylam-report-positive-topline-results-from-phase-2-study-kardia-1-of-zilebesiran-an-investigational-rnai-therapeutic-in-development-to-treat-hypertension-in-patients-at-high-risk-of-cardi/ 2023-09-08T11:55:43+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/report-_2_.webp https://thepharmadata.com/bristol-myers-squibb-celebrates-a-decade-of-its-coast-2-coast-4-cancer-cross-country-bike-ride-in-support-of-the-v-foundation-for-cancer-research/ 2023-09-08T11:52:39+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/cancer-treatment.webp https://thepharmadata.com/first-in-class-targeted-microrna-therapy-slows-cancer-tumor-growth/ 2023-09-06T04:54:10+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/brain-tumors.webp https://thepharmadata.com/why-breast-cancer-survivors-dont-take-their-medication-and-what-can-be-done/ 2023-09-06T04:51:54+00:00 https://thepharmadata.com/wp-content/uploads/2023/09/breast-cancer.webp https://thepharmadata.com/roches-alecensa-delivers-unprecedented-phase-iii-results-for-people-with-alk-positive-early-stage-lung-cancer/ 2023-09-02T06:32:00+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/lung-cancer.webp https://thepharmadata.com/amgen-and-horizon-therapeutics-plc-resolve-ftc-lawsuit-clearing-path-to-close-acquisition/ 2023-09-02T06:27:24+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/publish.webp https://thepharmadata.com/amgen-to-present-at-the-2023-wells-fargo-healthcare-conference-and-the-citi-global-healthcare-conference/ 2023-09-02T06:18:49+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Conference.webp https://thepharmadata.com/sanofi-announces-changes-to-its-executive-committee/ 2023-09-02T06:17:15+00:00 https://thepharmadata.com/wp-content/uploads/2023/08/Announces-3.webp https://thepharmadata.com/bayer-to-invest-eur-220-million-in-new-rd-facility-at-its-monheim-site/ 2023-09-02T06:08:00+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Investment-scaled.webp https://thepharmadata.com/ad-hoc-announcement-pursuant-to-art-53-lr-roche-provides-update-on-phase-iii-skyscraper-01-study-in-pd-l1-high-metastatic-non-small-cell-lung-cancer/ 2023-08-29T05:57:02+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announcement.webp https://thepharmadata.com/european-commission-approves-roches-evrysdi-for-babies-under-two-months-old-with-spinal-muscular-atrophy/ 2023-08-29T05:46:45+00:00 https://thepharmadata.com/wp-content/uploads/2023/08/spinal-muscular-atrophy.webp https://thepharmadata.com/oman-health-exhibition-and-conference-2023-pioneering-healthcare/ 2023-08-24T07:40:31+00:00 https://thepharmadata.com/wp-content/uploads/2023/08/OHEC-PR-1-scaled.jpg https://thepharmadata.com/johnson-johnson-announces-preliminary-results-of-kenvue-inc-exchange-offer/ 2023-08-24T05:05:43+00:00 https://thepharmadata.com/wp-content/uploads/2023/08/Announces-3.webp https://thepharmadata.com/u-s-fda-approves-abrysvo-pfizers-vaccine-for-the-prevention-of-respiratory-syncytial-virus-rsv-in-infants-through-active-immunization-of-pregnant-individuals-32-36-weeks-of-gesta/ 2023-08-24T04:57:40+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/vaccine-scaled.webp https://thepharmadata.com/amgen-to-discuss-application-for-lumakras-sotorasib-for-the-treatment-of-kras-g12c-positive-nsclc-at-fda-advisory-committee-meeting/ 2023-08-24T04:53:39+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Meeting-_4_.webp https://thepharmadata.com/european-commission-approves-reduced-dosing-frequency-for-janssens-bispecific-antibody-tecvayli%e2%96%bc-teclistamab/ 2023-08-19T06:13:59+00:00 https://thepharmadata.com/wp-content/uploads/2023/08/pexels-karolina-grabowska-4226924.webp https://thepharmadata.com/merck-announces-welireg-belzutifan-phase-3-litespark-005-trial-met-primary-endpoint-of-progression-free-survival-in-certain-previously-treated-patients-with-advanced-renal-cell-carcinoma/ 2023-08-19T06:10:52+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces-2.webp https://thepharmadata.com/gilead-sciences-and-meharry-medical-college-highlight-five-year-impact-of-gilead-compass-initiative-on-hiv-in-the-southern-united-states/ 2023-08-19T06:06:38+00:00 https://thepharmadata.com/wp-content/uploads/2023/08/pexels-louis-bauer-249348.webp https://thepharmadata.com/moderna-clinical-trial-data-confirm-its-updated-covid-19-vaccine-generates-robust-immune-response-in-humans-against-widely-circulating-variants/ 2023-08-19T04:31:39+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/COVID-19.webp https://thepharmadata.com/cancer-infecting-virus-warms-up-cold-tumors-and-improves-immunotherapy/ 2023-08-16T05:38:00+00:00 https://thepharmadata.com/wp-content/uploads/2023/08/pexels-edward-jenner-4033151.webp https://thepharmadata.com/pfizers-elrexfio-receives-u-s-fda-accelerated-approval-for-relapsed-or-refractory-multiple-myeloma/ 2023-08-16T05:34:06+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/approval.webp https://thepharmadata.com/novartis-completes-acquisition-of-chinook-therapeutics/ 2023-08-12T07:50:44+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Conference.webp https://thepharmadata.com/novartis-remibrutinib-phase-iii-trials-met-their-primary-endpoints-and-showed-rapid-symptom-control-in-chronic-spontaneous-urticaria/ 2023-08-12T07:49:14+00:00 https://thepharmadata.com/wp-content/uploads/2023/08/pexels-karolina-grabowska-4021775.jpg https://thepharmadata.com/novo-nordisk-to-acquire-inversago-pharma-to-develop-new-therapies-for-people-living-with-obesity-diabetes-and-other-serious-metabolic-diseases/ 2023-08-12T07:42:54+00:00 https://thepharmadata.com/wp-content/uploads/2023/08/pexels-rdne-stock-project-6129158.webp https://thepharmadata.com/novo-nordisk-a-s-semaglutide-2-4-mg-reduces-the-risk-of-major-adverse-cardiovascular-events-by-20-in-adults-with-overweight-or-obesity-in-the-select-trial/ 2023-08-12T07:39:01+00:00 https://thepharmadata.com/wp-content/uploads/2023/08/pexels-thirdman-7659573.webp https://thepharmadata.com/fda-approves-zurzuvae-zuranolone-the-first-and-only-oral-treatment-approved-for-women-with-postpartum-depression-and-issues-a-complete-response-letter-for-major-depressive-disorder-2/ 2023-08-12T07:22:57+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Approves.webp https://thepharmadata.com/fda-approves-zurzuvae-zuranolone-the-first-and-only-oral-treatment-approved-for-women-with-postpartum-depression-and-issues-a-complete-response-letter-for-major-depressive-disorder/ 2023-08-07T04:23:33+00:00 https://thepharmadata.com/wp-content/uploads/2023/08/pexels-jonathan-borba-4687906.webp https://thepharmadata.com/ai-drives-a-new-era-of-target-identification-and-drug-design/ 2023-08-03T11:45:11+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/drug-dependence.webp https://thepharmadata.com/learning-how-to-control-hiv-from-african-genomes/ 2023-08-03T11:43:25+00:00 https://thepharmadata.com/wp-content/uploads/2023/08/pexels-towfiqu-barbhuiya-10963257.webp https://thepharmadata.com/new-rna-based-therapy-combats-melanoma-in-mouse-models/ 2023-07-29T06:36:41+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/RNA-based-therapy.webp https://thepharmadata.com/johnson-johnson-subsidiary-to-appeal-bankruptcy-court-ruling-that-deprived-talc-claimants-of-an-equitable-and-efficient-resolution/ 2023-07-29T06:33:20+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Meeting-_4_.webp https://thepharmadata.com/astrazeneca-appoints-sharon-barr-as-executive-vice-president-biopharmaceuticals-rd/ 2023-07-29T06:28:19+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/pexels-sora-shimazaki-5668859.webp https://thepharmadata.com/merck-announces-phase-3-keynote-756-trial-met-primary-endpoint-of-pathological-complete-response-pcr-rate-in-patients-with-high-risk-early-stage-er-her2-breast-cancer/ 2023-07-29T06:25:34+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Pathological.webp https://thepharmadata.com/pfizer-announces-executive-leadership-to-advance-oncology-research-and-development-strategy/ 2023-07-29T06:21:13+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announcement.webp https://thepharmadata.com/enhertu-demonstrated-clinically-meaningful-progression-free-survival-and-overall-survival-across-multiple-her2-expressing-advanced-solid-tumors-in-destiny-pantumor02-phase-ii-trial/ 2023-07-29T06:19:37+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/clinical-4.webp https://thepharmadata.com/merck-and-moderna-initiate-phase-3-study-evaluating-v940-mrna-4157-in-combination-with-keytruda-pembrolizumab-for-adjuvant-treatment-of-patients-with-resected-high-risk-stage-iib-iv-melano/ 2023-07-29T06:16:06+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Treatment-_4_.webp https://thepharmadata.com/roche-enters-partnership-with-alnylam-to-co-develop-and-co-commercialise-rnai-therapeutic-zilebesiran-to-treat-hypertension-in-patients-with-high-cardiovascular-risk/ 2023-07-29T06:11:18+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/partnership.webp https://thepharmadata.com/sandoz-receives-positive-chmp-opinion-for-multiple-sclerosis-biosimilar-natalizumab/ 2023-07-29T06:08:58+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/disease.webp https://thepharmadata.com/twice-yearly-lenacapavir-demonstrates-sustained-impact-on-health-related-quality-of-life-in-people-with-hiv/ 2023-07-29T06:04:19+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/HIV.webp https://thepharmadata.com/cvs-pharmacy-introduces-new-universal-tools-collection-from-oneother/ 2023-07-29T06:01:55+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Pharmacy.webp https://thepharmadata.com/new-clinical-and-real-world-data-for-roches-vabysmo-at-asrs-reveal-improved-outcomes-for-people-with-two-leading-causes-of-vision-loss/ 2023-07-22T05:09:50+00:00 https://thepharmadata.com/wp-content/uploads/2023/06/Clinical-_3_.webp https://thepharmadata.com/pfizer-announces-post-tornado-relief-plans-for-rocky-mount-community-and-manufacturing-facility/ 2023-07-22T05:07:22+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces.webp https://thepharmadata.com/gilead-announces-8-million-in-grant-funding-for-viral-hepatitis-relink-program-in-the-u-s/ 2023-07-22T05:01:27+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announces-2.webp https://thepharmadata.com/new-global-action-plan-on-epilepsy-and-other-neurological-disorders-published/ 2023-07-22T04:57:05+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/neurological.webp https://thepharmadata.com/fda-grants-full-approval-for-blincyto-blinatumomab-to-treat-minimal-residual-disease-positive-b-cell-precursor-acute-lymphoblastic-leukemia/ 2023-07-22T04:53:55+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/APPROVAL-_2_.webp https://thepharmadata.com/abbvie-receives-positive-chmp-opinion-for-epcoritamab-tepkinly-for-the-treatment-of-adults-with-relapsed-refractory-diffuse-large-b-cell-lymphoma-dlbcl/ 2023-07-22T04:47:44+00:00 https://thepharmadata.com/wp-content/uploads/2023/07/Treatment-_4_.webp https://thepharmadata.com/ositive-phase-iii-results-for-roches-ocrevus-ocrelizumab-twice-a-year-10-minute-subcutaneous-injection-in-patients-with-multiple-sclerosis/ 2023-07-20T05:32:04+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/Vaccination.webp https://thepharmadata.com/flagship-pioneering-and-pfizer-partner-to-accelerate-development-of-innovative-medicines-targeting-unmet-needs/ 2023-07-19T11:31:46+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/Medicines.webp https://thepharmadata.com/astrazeneca-announces-400-million-investment-in-reforestation-and-biodiversity-in-support-of-climate-action-and-human-health-2/ 2023-07-19T11:30:31+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/Announcement.webp https://thepharmadata.com/gilead-partners-with-chai-and-penta-to-improve-treatment-and-adherence-rates-among-children-with-hiv-in-low-and-middle-income-countries/ 2023-07-15T07:50:22+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/treatment-of-children-1.webp https://thepharmadata.com/fda-approves-veklury-remdesivir-for-covid-19-treatment-in-patients-with-severe-renal-impairment-including-those-on-dialysis/ 2023-07-15T07:48:45+00:00 https://thepharmadata.com/wp-content/uploads/2023/05/COVID-19.webp https://thepharmadata.com/abbvie-secures-positive-chmp-opinion-for-atogepant-for-the-preventive-treatment-of-adults-with-migraine/ 2023-07-11T11:16:12+00:00 https://thepharmadata.com/wp-content/uploads/2023/04/treatment-_2_-scaled.webp